Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells

Tanya Gritsko, Ann H. Williams, James Turkson et al. · Clinical Cancer Research · 2006 · 566 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

Anthony J. Raffo, Harris Perlman, Min‐Wei Chen et al. · PubMed · 1995 · 551 citations

Medicine, Oncology, Urology +15

Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.

Limin Hu, Judith Hofmann, Yiling Lu et al. · PubMed · 2002 · 362 citations

Medicine, Oncology, Pharmacology +17

Interleukin-6, Secreted by Human Ovarian Carcinoma Cells, Is a Potent Proangiogenic Cytokine

Monique B. Nilsson, Robert R. Langley, Isaiah J. Fidler · Cancer Research · 2005 · 349 citations · Full text

Medicine, Cell Biology, Oncology +16

The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.

Aristides G. Eliopoulos, J. Herod, L Hodgkins et al. · PubMed · 1995 · 301 citations

Medicine, Cancer Biology, Oncology +14